Patricia G. Synnott

Statistics

Publications

Citations

165

H-Index

Active since

2017

Affiliations

Institute for Clinical and Economic Review(Current)

Tufts Medical Center

University of Washington

Patricia G. Synnott is an author at Institute for Clinical and Economic Review specializing in pharmacoeconomics, cost-effectiveness analysis, and cost-effectiveness modeling.

ORCID

Publications per year

2017–2023

Publications

Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

Marita Zimmermann, Solomon J. Lubinga, Reiner Banken et al. · Value in Health · 2018 · 56 citations · Full text

Medicine, Ophthalmology, Pharmacoeconomics +12

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States

Josh J. Carlson, Gregory F. Guzauskas, Richard H. Chapman et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 48 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

The effectiveness and value of aducanumab for Alzheimer’s disease

Patricia G. Synnott, Melanie D. Whittington, Grace A. Lin et al. · Journal of Managed Care & Specialty Pharmacy · 2021 · 26 citations · Full text

Medicine, Geriatric Medicine, Pharmacoeconomics +16

Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model

Varun Kumar, Foluso Agboola, Patricia G. Synnott et al. · Value in Health · 2019 · 13 citations

Pharmacy, Pharmacoeconomics, Pharmacology +15

The impact of external reference pricing on pharmaceutical costs and market dynamics

Dominic Voehler, Benjamin Koethe, Patricia G. Synnott et al. · Health Policy OPEN · 2023 · 12 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +15

1–5 of 6